Monovalent Group B Streptococcus glycoconjugate vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Monovalent Group B Streptococcus glycoconjugate vaccine, covering 2011-12-08 to 2011-12-08. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of a Monovalent Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18-40 Years of Age [Phase 1]